Is Diebold Nixdorf, Incorporated (DBD) overvalued? · P/E 28, rev $3.75B
Diebold Nixdorf, Incorporated (DBD) is a software - application company listed on US.
This page asks whether Diebold Nixdorf, Incorporated (DBD) looks expensive on cached numbers — not a short thesis.
Latest reported DBD revenue for 2024-12-31 was $3.75B. Net income was -$14.5M. Revenue was up 130.3% from 2023-12-31 to 2024-12-31. DBD currently screens at market cap $2.82B and trailing P/E 28.1.
DBD currently screens at market cap $2.82B and trailing P/E 28.1. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next DBD 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the DBD stock page for the full model, not this heading.
Not investment advice.